Longitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity.
Jinzi ZhengStephan G KlinzRaquel De SouzaJonathan FitzgeraldDavid A JaffrayPublished in: EJNMMI research (2015)
These findings highlight the potential use of FAZA-PET as an early marker of treatment response following multi-dose chemotherapy.